CPT® Code 88175 is used to report a cervical or vaginal cytopathology test (Pap test) performed using automated thin-layer preparation technology, including screening by an automated system, manual rescreening when indicated, and physician interpretation.
Pap testing is a key component of cervical cancer screening, helping identify abnormal cellular changes that may indicate precancerous lesions, human papillomavirus (HPV)-related changes, or cervical cancer.
This code includes specimen preparation, screening, and physician interpretation of the results.
Key Facts About CPT® 88175
- Service type: Laboratory test (cytopathology)
- Test: Cervical or vaginal cytology (Pap test)
- Method: Automated thin-layer preparation
- Includes: Automated screening, manual rescreening when indicated, and physician interpretation
- Specimen type: Cervical and/or vaginal cell sample
- Provider type: Cytopathologists, pathologists, laboratories, physicians, and qualified healthcare professionals
Common clinical indications:
- Routine cervical cancer screening
- Follow-up of previous abnormal Pap test results
- Preventive women's health examinations
- Surveillance of patients at increased risk for cervical dysplasia
- Evaluation of abnormal cervical findings
When to Use CPT® 88175
CPT 88175 is appropriate when:
- Performing a Pap test using automated thin-layer preparation technology
- Automated screening is utilized as part of the testing process
- Physician interpretation of cytology findings is included
- Screening or diagnostic cervical cytology testing is medically appropriate
Examples:
- Routine cervical cancer screening during a well-woman examination
- Follow-up cytology testing after a previous abnormal Pap result
- Cervical cancer surveillance for high-risk patients
- Evaluation of abnormal cervical findings identified during a gynecologic examination
Documentation Requirements
To support CPT 88175 billing, documentation should include:
- Patient identifiers and date of service
- Clinical indication for testing
- Specimen source and collection details
- Cytology test performed (automated thin-layer Pap test)
- Laboratory findings and interpretation
- Physician interpretation and final report
- Ordering provider information
Complete documentation supports medical necessity and accurate laboratory billing.
Reimbursement and Coding Considerations
- CPT 88175 includes automated screening, manual rescreening when indicated, and physician interpretation
- Commonly covered as part of preventive women's health services, subject to payer guidelines
- May be performed with HPV testing when clinically indicated, though HPV testing is billed separately when applicable
- Coverage frequency may vary based on patient age, risk factors, and payer policies
- Diagnosis coding should support preventive screening or diagnostic evaluation when applicable
Always verify payer-specific cervical cancer screening and laboratory billing requirements.
How OptiMantra Supports Women's Health and Preventive Screening
OptiMantra’s integrated EMR and practice management system streamlines documentation and billing for CPT 88175:
With OptiMantra, providers can:
- Document Pap tests and gynecologic examinations within the patient chart
- Track screening histories and preventive care schedules
- Integrate laboratory results into patient records through connected lab integrations and results management workflows
- Link cytology findings to follow-up recommendations and treatment plans
- Maintain organized clinical and laboratory documentation that supports billing compliance and audit preparedness
- Manage preventive care workflows from screening through follow-up care
By centralizing women's health documentation and laboratory workflows, OptiMantra helps practices improve efficiency, ensure compliance, and optimize reimbursement.
Try OptiMantra for free here!
Disclaimer: CPT® codes are maintained by the American Medical Association. This guide is for informational purposes only and does not replace official coding guidelines or payer policies.
.png)
